Quantitative BioSciences
Quantitative BioSciences, Inc. (QBI), established in 2010, specializes in developing customized, multiplexed biosensors and single-domain antibody (VHH) services. Their core platform, nanoQube, integrates nanobodies into engineered bacterial sensor strains for continuous, automated, and in-line quantification of proteins and other targets in aqueous solutions. QBI's technology combines synthetic biology, advanced cell measurement, and machine learning, with applications in pharmaceutical process control, water quality monitoring, agriculture, and industrial monitoring. They offer rapid, inexpensive VHH services, delivering single-domain antibodies in 3-4 weeks starting at $10,000 per target, emphasizing animal-free, high-diversity libraries and customization. The company has a strong track record with over 20 projects funded by various government agencies including NIH, DOE, DARPA, IARPA, USDA, and EPA.
Quantitative BioSciences
Quantitative BioSciences, Inc. (QBI), established in 2010, specializes in developing customized, multiplexed biosensors and single-domain antibody (VHH) services. Their core platform, nanoQube, integrates nanobodies into engineered bacterial sensor strains for continuous, automated, and in-line quantification of proteins and other targets in aqueous solutions. QBI's technology combines synthetic biology, advanced cell measurement, and machine learning, with applications in pharmaceutical process control, water quality monitoring, agriculture, and industrial monitoring. They offer rapid, inexpensive VHH services, delivering single-domain antibodies in 3-4 weeks starting at $10,000 per target, emphasizing animal-free, high-diversity libraries and customization. The company has a strong track record with over 20 projects funded by various government agencies including NIH, DOE, DARPA, IARPA, USDA, and EPA.